About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cdh1+
wild type
MGI:2430281
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Vil1-cre)20Syr/0
involves: 129 * C57BL/6 * DBA/2 MGI:5634401
cn2
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
involves: 129 * C57BL/6 * FVB/N MGI:5634403
cn3
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
involves: 129 * C57BL/6 * FVB/N MGI:5634400
cn4
Cdh1tm2Kem/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N MGI:5634406
cn5
Cdh1tm1Jjon/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)51Nki/0
involves: 129P2/OlaHsd * FVB/N MGI:6296608
cn6
Cdh1tm1Jjon/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
involves: 129P2/OlaHsd * FVB/N MGI:3695273
cx7
Apctm1Rak/Apc+
Cdh1tm1Cbm/Cdh1+
involves: 129P2/OlaHsd * C57BL/6J MGI:3830619


Genotype
MGI:5634401
cn1
Allelic
Composition
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Vil1-cre)20Syr/0
Genetic
Background
involves: 129 * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdh1tm2Kem mutation (1 available); any Cdh1 mutation (173 available)
Smad4tm2.1Cxd mutation (2 available); any Smad4 mutation (46 available)
Tg(Vil1-cre)20Syr mutation (4 available)
Trp53tm1Brn mutation (21 available); any Trp53 mutation (249 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice develop intestinal adenocarcinomas with a median tumor-free survival of 5.2 months of age and no distant metastases are seen

digestive/alimentary system
• mice develop intestinal adenocarcinomas with a median tumor-free survival of 5.2 months of age and no distant metastases are seen




Genotype
MGI:5634403
cn2
Allelic
Composition
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
Genetic
Background
involves: 129 * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdh1tm2Kem mutation (1 available); any Cdh1 mutation (173 available)
Smad4tm2.1Cxd mutation (2 available); any Smad4 mutation (46 available)
Tg(MMTV-cre)7Mul mutation (0 available)
Trp53tm1Brn mutation (21 available); any Trp53 mutation (249 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice develop mammary gland carcinoma with a median tumor-free survival of 10.4 months of age
• tumors are invasive ductal carcinomas with a squamous component, however lobular carcinomas are not seen
• 33% of mice show lung metastasis

integument
• mice develop mammary gland carcinoma with a median tumor-free survival of 10.4 months of age
• tumors are invasive ductal carcinomas with a squamous component, however lobular carcinomas are not seen

endocrine/exocrine glands
• mice develop mammary gland carcinoma with a median tumor-free survival of 10.4 months of age
• tumors are invasive ductal carcinomas with a squamous component, however lobular carcinomas are not seen




Genotype
MGI:5634400
cn3
Allelic
Composition
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
Genetic
Background
involves: 129 * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdh1tm2Kem mutation (1 available); any Cdh1 mutation (173 available)
Smad4tm2.1Cxd mutation (2 available); any Smad4 mutation (46 available)
Tg(Pdx1-cre)6Tuv mutation (4 available)
Trp53tm1Brn mutation (21 available); any Trp53 mutation (249 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• most common cause of death is duodenal obstruction, followed by gastric outlet obstruction

neoplasm
• 36% of mice develop duodenal adenocarcinomas
• 84% of mice develop spontaneous tumors in the glandular stomach with a median tumor-free survival of 8 months
• gastric tumors resemble diffuse-type gastric adenocarcinomas, are E-cadherin-negative, and are invasive into the muscle layers and regional lymph nodes
• intramucosal adenocarcinomas with signet ring cell feature is seen in 2 of 4 mice at 6 months of age
• gastric premalignant lesions such as atrophic gastritis, metaplasia or dysplasia are not seen at 4 and 5 months of age
• 3 of 21 mice with gastric adenocarcinomas develop lung metastases
• metastatic lesions have similar cytologic features to primary gastric tumors
• 8% of mice exhibit adenocarcinomas in the pancreas, most likely due to invasion of the primary duodenal or gastric adenocarcinomas
• 24% of mice develop forestomach squamous cell carcinomas

digestive/alimentary system
• 36% of mice develop duodenal adenocarcinomas
• 84% of mice develop spontaneous tumors in the glandular stomach with a median tumor-free survival of 8 months
• gastric tumors resemble diffuse-type gastric adenocarcinomas, are E-cadherin-negative, and are invasive into the muscle layers and regional lymph nodes
• intramucosal adenocarcinomas with signet ring cell feature is seen in 2 of 4 mice at 6 months of age
• gastric premalignant lesions such as atrophic gastritis, metaplasia or dysplasia are not seen at 4 and 5 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
stomach cancer DOID:10534 OMIM:613659
J:212549




Genotype
MGI:5634406
cn4
Allelic
Composition
Cdh1tm2Kem/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdh1tm2Kem mutation (1 available); any Cdh1 mutation (173 available)
Tg(Pdx1-cre)6Tuv mutation (4 available)
Trp53tm1Brn mutation (21 available); any Trp53 mutation (249 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• mice do not develop gastric adenocarcinomas




Genotype
MGI:6296608
cn5
Allelic
Composition
Cdh1tm1Jjon/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)51Nki/0
Genetic
Background
involves: 129P2/OlaHsd * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdh1tm1Jjon mutation (1 available); any Cdh1 mutation (173 available)
Tg(Wap-cre)51Nki mutation (0 available)
Trp53tm1Brn mutation (21 available); any Trp53 mutation (249 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• females develop mammary tumors with a median latency of around 290 days
• mammary tumors are either intermediate-grade adenocarcinoma or solid carcinoma/carcinosarcoma
• virgin females develop mammary tumors with identical incidence and latency as uniparous females
• tumor spectrum, invasiveness and metastatic dissemination are similar in virgin and parous females
• some mice develop intermediate-grade adenocarcinoma

integument
• females develop mammary tumors with a median latency of around 290 days
• mammary tumors are either intermediate-grade adenocarcinoma or solid carcinoma/carcinosarcoma
• virgin females develop mammary tumors with identical incidence and latency as uniparous females
• tumor spectrum, invasiveness and metastatic dissemination are similar in virgin and parous females
• some mice develop intermediate-grade adenocarcinoma

neoplasm
• females develop mammary tumors with a median latency of around 290 days
• mammary tumors are either intermediate-grade adenocarcinoma or solid carcinoma/carcinosarcoma
• virgin females develop mammary tumors with identical incidence and latency as uniparous females
• tumor spectrum, invasiveness and metastatic dissemination are similar in virgin and parous females
• some mice develop intermediate-grade adenocarcinoma




Genotype
MGI:3695273
cn6
Allelic
Composition
Cdh1tm1Jjon/Cdh1+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
Genetic
Background
involves: 129P2/OlaHsd * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdh1tm1Jjon mutation (1 available); any Cdh1 mutation (173 available)
Tg(KRT14-cre)8Brn mutation (4 available)
Trp53tm1Brn mutation (21 available); any Trp53 mutation (249 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice show longer tumor latency periods (330 days) compared to double conditional knockouts (214 days)
• most tumors are intermediate grade adenocarcinomas or high-grade solid carcinomas characterized by expansive growth pattern with large epithelial cells forming solid nest or irregular glands
• some tumors have a carcinosarcoma phenotype (elements of carcinoma and sarcoma) involving epithelial and mesenchymal elements with a metaphasic and biphasic histology
• small numbers of skin carcinomas develop with latency of 330 days develop
• may be classified as pilomatriculomas or squamous cell carcinomas, without metastasis

integument
• mice show longer tumor latency periods (330 days) compared to double conditional knockouts (214 days)
• most tumors are intermediate grade adenocarcinomas or high-grade solid carcinomas characterized by expansive growth pattern with large epithelial cells forming solid nest or irregular glands
• some tumors have a carcinosarcoma phenotype (elements of carcinoma and sarcoma) involving epithelial and mesenchymal elements with a metaphasic and biphasic histology
• small numbers of skin carcinomas develop with latency of 330 days develop
• may be classified as pilomatriculomas or squamous cell carcinomas, without metastasis

endocrine/exocrine glands
• mice show longer tumor latency periods (330 days) compared to double conditional knockouts (214 days)
• most tumors are intermediate grade adenocarcinomas or high-grade solid carcinomas characterized by expansive growth pattern with large epithelial cells forming solid nest or irregular glands
• some tumors have a carcinosarcoma phenotype (elements of carcinoma and sarcoma) involving epithelial and mesenchymal elements with a metaphasic and biphasic histology




Genotype
MGI:3830619
cx7
Allelic
Composition
Apctm1Rak/Apc+
Cdh1tm1Cbm/Cdh1+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Apctm1Rak mutation (1 available); any Apc mutation (156 available)
Cdh1tm1Cbm mutation (0 available); any Cdh1 mutation (173 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice develop an average of 11.3 tumors per animal in the small intestine unlike wild-type mice
• mice develop more tumors than in Apctm1Rak heterozygotes with tumor size the same as in Apctm1Rak heterozygotes
• tumors are invasive although no metastasis is detected
• 5-fold more mice develop gastric cancer compared to in Apctm1Rak heterozygotes

digestive/alimentary system
• mice develop an average of 11.3 tumors per animal in the small intestine unlike wild-type mice
• mice develop more tumors than in Apctm1Rak heterozygotes with tumor size the same as in Apctm1Rak heterozygotes
• tumors are invasive although no metastasis is detected
• 5-fold more mice develop gastric cancer compared to in Apctm1Rak heterozygotes





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/18/2025
MGI 6.24
The Jackson Laboratory